- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23Q4 (20) | 9.99 | -19.69 | -47.31 | 0.25 | 78.57 | 66.67 | 0.43 | 16.22 | -20.37 | 0.74 | -2.63 | -11.9 | 2.50 | 122.37 | 216.32 | 4.30 | 44.72 | 51.13 | 7.41 | 21.25 | 67.2 | 0 | 0 | 0 |
23Q3 (19) | 12.44 | 77.71 | -34.56 | 0.14 | 40.0 | 16.67 | 0.37 | 68.18 | 8.82 | 0.76 | 13.43 | 4.11 | 1.13 | -21.22 | 78.28 | 2.97 | -5.36 | 66.3 | 6.11 | -36.17 | 59.09 | 0 | 0 | 0 |
23Q2 (18) | 7.0 | -18.79 | -40.48 | 0.1 | -33.33 | -16.67 | 0.22 | -31.25 | -60.71 | 0.67 | -9.46 | 9.84 | 1.43 | -17.9 | 40.0 | 3.14 | -15.34 | -34.0 | 9.57 | 11.49 | 84.52 | 0 | 0 | 0 |
23Q1 (17) | 8.62 | -54.54 | 10.51 | 0.15 | 0.0 | 25.0 | 0.32 | -40.74 | 77.78 | 0.74 | -11.9 | 27.59 | 1.74 | 119.95 | 13.11 | 3.71 | 30.34 | 60.87 | 8.58 | 93.77 | 15.45 | 0 | 0 | 0 |
22Q4 (16) | 18.96 | -0.26 | 83.9 | 0.15 | 25.0 | 15.38 | 0.54 | 58.82 | 134.78 | 0.84 | 15.07 | 16.67 | 0.79 | 25.33 | -37.26 | 2.85 | 59.24 | 27.67 | 4.43 | 15.37 | -36.56 | 0 | 0 | 0 |
22Q3 (15) | 19.01 | 61.65 | 108.21 | 0.12 | 0.0 | 0.0 | 0.34 | -39.29 | 100.0 | 0.73 | 19.67 | 5.8 | 0.63 | -38.14 | -51.97 | 1.79 | -62.44 | -3.95 | 3.84 | -25.97 | -49.19 | 0 | 0 | 0 |
22Q2 (14) | 11.76 | 50.77 | 23.92 | 0.12 | 0.0 | 0.0 | 0.56 | 211.11 | 211.11 | 0.61 | 5.17 | -11.59 | 1.02 | -33.67 | -19.3 | 4.76 | 106.35 | 151.06 | 5.19 | -30.24 | -28.66 | 0 | 0 | 0 |
22Q1 (13) | 7.8 | -24.35 | -25.93 | 0.12 | -7.69 | 0.0 | 0.18 | -21.74 | 12.5 | 0.58 | -19.44 | 1.75 | 1.54 | 22.01 | 35.0 | 2.31 | 3.44 | 51.88 | 7.44 | 6.48 | 37.37 | 0 | 0 | 0 |
21Q4 (12) | 10.31 | 12.92 | -25.4 | 0.13 | 8.33 | 8.33 | 0.23 | 35.29 | 27.78 | 0.72 | 4.35 | 7.46 | 1.26 | -4.07 | 45.22 | 2.23 | 19.81 | 71.28 | 6.98 | -7.59 | 44.05 | 0 | 0 | 0 |
21Q3 (11) | 9.13 | -3.79 | -28.28 | 0.12 | 0.0 | 0.0 | 0.17 | -5.56 | 0.0 | 0.69 | 0.0 | 0.0 | 1.31 | 3.94 | 39.43 | 1.86 | -1.83 | 39.43 | 7.56 | 3.94 | 39.43 | 0 | 0 | 0 |
21Q2 (10) | 9.49 | -9.88 | -24.08 | 0.12 | 0.0 | -29.41 | 0.18 | 12.5 | 0.0 | 0.69 | 21.05 | -1.43 | 1.26 | 10.96 | -7.02 | 1.90 | 24.83 | 31.72 | 7.27 | 34.32 | 29.84 | 0 | 0 | 0 |
21Q1 (9) | 10.53 | -23.81 | 13.35 | 0.12 | 0.0 | -20.0 | 0.16 | -11.11 | 6.67 | 0.57 | -14.93 | -14.93 | 1.14 | 31.24 | -29.42 | 1.52 | 16.66 | -5.89 | 5.41 | 11.66 | -24.94 | 0 | 0 | 0 |
20Q4 (8) | 13.82 | 8.56 | 0.88 | 0.12 | 0.0 | 20.0 | 0.18 | 5.88 | -10.0 | 0.67 | -2.9 | 9.84 | 0.87 | -7.89 | 18.96 | 1.30 | -2.47 | -10.78 | 4.85 | -10.56 | 8.88 | 0 | 0 | 0 |
20Q3 (7) | 12.73 | 1.84 | -14.16 | 0.12 | -29.41 | -50.0 | 0.17 | -5.56 | -5.56 | 0.69 | -1.43 | -11.54 | 0.94 | -30.69 | -41.75 | 1.34 | -7.26 | 10.02 | 5.42 | -3.21 | 3.05 | 0 | 0 | 0 |
20Q2 (6) | 12.5 | 34.55 | -6.99 | 0.17 | 13.33 | -32.0 | 0.18 | 20.0 | 28.57 | 0.7 | 4.48 | 0.0 | 1.36 | -15.77 | -26.89 | 1.44 | -10.82 | 38.24 | 5.60 | -22.35 | 7.52 | 0 | 0 | 0 |
20Q1 (5) | 9.29 | -32.19 | -38.52 | 0.15 | 50.0 | -28.57 | 0.15 | -25.0 | -16.67 | 0.67 | 9.84 | -2.9 | 1.61 | 121.21 | 16.18 | 1.61 | 10.6 | 35.54 | 7.21 | 61.98 | 57.93 | 0 | 0 | 0 |
19Q4 (4) | 13.7 | -7.62 | 0.0 | 0.1 | -58.33 | 0.0 | 0.2 | 11.11 | 0.0 | 0.61 | -21.79 | 0.0 | 0.73 | -54.9 | 0.0 | 1.46 | 20.28 | 0.0 | 4.45 | -15.34 | 0.0 | 0 | 0 | 0.0 |
19Q3 (3) | 14.83 | 10.34 | 0.0 | 0.24 | -4.0 | 0.0 | 0.18 | 28.57 | 0.0 | 0.78 | 11.43 | 0.0 | 1.62 | -13.0 | 0.0 | 1.21 | 16.52 | 0.0 | 5.26 | 0.98 | 0.0 | 0 | 0 | 0.0 |
19Q2 (2) | 13.44 | -11.05 | 0.0 | 0.25 | 19.05 | 0.0 | 0.14 | -22.22 | 0.0 | 0.7 | 1.45 | 0.0 | 1.86 | 33.84 | 0.0 | 1.04 | -12.56 | 0.0 | 5.21 | 14.05 | 0.0 | 0 | 0 | 0.0 |
19Q1 (1) | 15.11 | 0.0 | 0.0 | 0.21 | 0.0 | 0.0 | 0.18 | 0.0 | 0.0 | 0.69 | 0.0 | 0.0 | 1.39 | 0.0 | 0.0 | 1.19 | 0.0 | 0.0 | 4.57 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 38.05 | -33.86 | 0.64 | 25.49 | 1.33 | -17.39 | 2.91 | 5.43 | 1.68 | 89.74 | 3.50 | 24.9 | 7.65 | 59.41 | 0 | 0 |
2022 (9) | 57.53 | 45.76 | 0.51 | 2.0 | 1.61 | 117.57 | 2.76 | 3.37 | 0.89 | -30.02 | 2.80 | 49.27 | 4.80 | -29.08 | 0 | 0 |
2021 (8) | 39.47 | -18.35 | 0.5 | -10.71 | 0.74 | 8.82 | 2.67 | -1.84 | 1.27 | 9.35 | 1.87 | 33.28 | 6.76 | 20.22 | 0 | 0 |
2020 (7) | 48.34 | -15.31 | 0.56 | -30.0 | 0.68 | -2.86 | 2.72 | -2.16 | 1.16 | -17.34 | 1.41 | 14.71 | 5.63 | 15.53 | 0 | 0 |
2019 (6) | 57.08 | -33.62 | 0.8 | -38.46 | 0.7 | 7.69 | 2.78 | -1.77 | 1.40 | -7.29 | 1.23 | 62.24 | 4.87 | 47.99 | 0 | 0 |
2018 (5) | 85.99 | -6.92 | 1.3 | -2.26 | 0.65 | -22.62 | 2.83 | -19.6 | 1.51 | 5.01 | 0.76 | -16.87 | 3.29 | -13.63 | 0 | 0 |
2017 (4) | 92.38 | -9.68 | 1.33 | -15.29 | 0.84 | -6.67 | 3.52 | -5.63 | 1.44 | -6.21 | 0.91 | 3.34 | 3.81 | 4.48 | 0 | 0 |
2016 (3) | 102.28 | -29.02 | 1.57 | -4.85 | 0.9 | -8.16 | 3.73 | -10.55 | 1.54 | 34.05 | 0.88 | 29.38 | 3.65 | 26.01 | 1967 | 0.0 |
2015 (2) | 144.09 | -10.39 | 1.65 | -27.63 | 0.98 | -5.77 | 4.17 | 1.46 | 1.15 | -19.24 | 0.68 | 5.15 | 2.89 | 13.22 | 1967 | 0.0 |
2014 (1) | 160.79 | 24.54 | 2.28 | 58.33 | 1.04 | -24.64 | 4.11 | 2.24 | 1.42 | 0 | 0.65 | 0 | 2.56 | 0 | 1967 | 0.0 |